Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home » DCH Auriga Selected Exclusive Distributor of Sinovac COVID-19 Vaccine in Hong Kong
    HealthCare

    DCH Auriga Selected Exclusive Distributor of Sinovac COVID-19 Vaccine in Hong Kong

    Marie JonesBy Marie JonesFebruary 18, 2021Updated:February 18, 2021No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    DCH Auriga, one of the largest healthcare distributors in Hong Kong, is pleased to announce it has been selected by the Hong Kong Department of Health to exclusively manage the storage and delivery of the Sinovac vaccine in Hong Kong.

    Under the agreement, DCH Auriga Hong Kong Ltd. will leverage its specialty cold chain expertise and unique healthcare-dedicated infrastructure for the safe and timely distribution of the Sinovac COVID-19 vaccine.

    Tim Collins, the CEO of DCH Auriga said, “We are honoured by the continued trust and support of the Hong Kong Department of Health and for the opportunity to leverage our capabilities to benefit our local community. With decades of experience managing pharmaceutical cold chain distribution, state-of-the-art facilities and robust quality assurance protocols, we are confident in our ability to safely and securely deliver the Sinovac vaccine in full accordance to the directives of the Government’s vaccination program.”

    About DCH Auriga

    DCH Auriga, a subsidiary of Dah Chong Hong Holdings Limited, is an Asia-based market management provider specialising in healthcare. Offering comprehensive commercial and logistics solutions, DCH Auriga partners with the world’s leading healthcare companies to distribute pharmaceuticals, medical devices, surgical equipment, diagnostics and OTC products for more than 500 brands into hospitals, pharmacies and specialty stores across Asia. DCH Auriga has operations in Hong Kong, Macao, mainland China, Singapore, Malaysia, Indonesia, Thailand and the Philippines.

    For more details, please visit www.dchauriga.com.

    Dah Chong Hong Holdings, an indirect wholly owned subsidiary of CITIC Limited (stock code: 0267.HK), is an integrated trading and distribution company operating in Asia, supported by an extensive logistics network. DCH is a leading distributor and dealer of motor vehicles in Greater China as well as a provider of a full range of associated services. DCH’s consumer business comprises the manufacture, retail and distribution of food, healthcare, electrical appliances, beauty and lifestyle products. DCH employs over 16,500 staff with operations in 12 Asian markets.

    For more details, please visit www.dch.com.hk.

    Media Enquires:

    DCH Communications | (852) 2768-2017 | dchcommunications@dch-holdings.com

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleChampion System Acquisition Accelerates Lever Style’s Active Wear and Custom Apparel Capability
    Next Article GBA Welcomes Venture Investment Platform DAO Maker as New Corporate Member

    Related Posts

    Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit

    May 22, 2026

    Graphene quantum dots show promise in targeting Parkinson’s-related protein clumping

    May 20, 2026

    Substantial Shareholder Wei Fu Increases Shareholding in Everest Medicines Again, Marking His Second Share Purchase in 2026 and Demonstrating Long-term Confidence

    May 15, 2026
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • PEVCJournal.com
    • Philippines Today

    Type above and press Enter to search. Press Esc to cancel.